Exploring the Davids and Goliaths of therapeutic molecules
A*STAR inks deals with Siena Biotech to develop small- and large-molecule therapies for cancer and bone loss diseases
12-Apr-2010 -
Two research units under Singapore’s Agency for Science, Technology and Research (A*STAR), the Experimental Therapeutics Centre (ETC) and Singapore Immunology Network (SIgN), are collaborating with Italy’s Siena Biotech S.p.A. to develop new drugs and targeted antibodies respectively, which will ...
antibodies
clinical trials
diseases
+7